Join the Nplate group to help and get support from people like you.
Nplate News
Nplate (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia
THOUSAND OAKS, Calif., Oct. 18, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) approved Amgen's Supplemental Biologics License Application (s...
FDA Approves Nplate (Romiplostim) For Use In Pediatric Patients With Immune Thrombocytopenia
THOUSAND OAKS, Calif., Dec. 14, 2018 /PRNewswire/ – Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for...
Ask a question
To post your own question to this support group, sign in or create an account.